Showing results (1061-1070 of 1,585) with videos related to
Sort By:
Pageof 159
British Journal of Haematology|November 13, 2001
Can positron emission tomography with [(18)F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity?K Spaepen, S Stroobants, P Dupont, et al.Antiviral Research|April 1, 1992
Different pattern of activity of inhibitors of the human immunodeficiency virus in lymphocytes and monocyte/macrophagesC F Perno, R Yarchoan, J Balzarini, et al.Journal of Medicinal Chemistry|March 31, 2011
Crystal structure of tert-butyldimethylsilyl-spiroaminooxathioledioxide-thymine (TSAO-T) in complex with HIV-1 reverse transcriptase (RT) redefines the elastic limits of the non-nucleoside inhibitor-binding pocketKalyan Das, Joseph D Bauman, Angela S Rim, et al.Journal of Medicinal Chemistry|January 11, 2001
Highly potent and selective inhibition of varicella-zoster virus by bicyclic furopyrimidine nucleosides bearing an aryl side chainC McGuigan, H Barucki, A Carangio, et al.Methods in Molecular Medicine|February 19, 2011
Evaluating Clinical Isolates for Their Phenotypic and Genotypic Resistance Against Anti-HIV DrugsA M Vandamme, M Witvrouw, C Pannecouque, et al.RNA Biology|March 2, 2011
Measuring cooperative Rev protein-protein interactions on Rev responsive RNA by fluorescence resonance energy transferThomas Vercruysse, Sonalika Pawar, Wim De Borggraeve, et al.Antimicrobial Agents and Chemotherapy|March 1, 1997
Antiretroviral activities of acyclic nucleoside phosphonates [9-(2-phosphonylmethoxyethyl)adenine, 9-(2-phosphonylmethoxyethyl)guanine, (R)-9-(2-phosphonylmethoxypropyl)adenine, and MDL 74,968] in cell cultures and murine sarcoma virus-infected newborn NMRI miceJ Balzarini, T Vahlenkamp, H Egberink, et al.European Journal of Medicinal Chemistry|February 28, 2004
Cytotoxic and anticonvulsant aryloxyaryl Mannich bases and related compoundsSarvesh C Vashishtha, Gordon A Zello, Kurt H Nienaber, et al.Tumori|October 31, 1994
Possible correlation between some biologic effects and the clinical course in patients treated with continuous infusion of interleukin-2 plus alpha-2 interferon for metastatic renal cell carcinomaC Baiocchi, G Landonio, G Balzarini, et al.Virchows Archiv : an International Journal of Pathology|December 17, 2003
A novel cell line and xenograft model of ampulla of Vater adenocarcinomaClaudio Sorio, Patrick S Moore, Maria Grazia Ennas, et al.Pageof 159